study_id,year,design,effect_type,effect_point,ci_low,ci_high,n_treat,n_ctrl,risk_of_bias,doi,journal_id,intervention,control,outcome,duration_weeks,population
colloidal-silver_2018_1,2018,RCT,MD,-2.335,-2.526,-2.145,103,70,low,10.3872/j.low_quality_journal.2018.7199,low_quality_journal,Colloidal Silver supplement,Placebo,BUN (mg/dL),24,Elderly adults
colloidal-silver_2021_2,2021,cohort,MD,-1.216,-1.794,-0.639,75,97,low,10.4619/j.jacc.2021.2705,jacc,Colloidal Silver supplement,Control group,Proteinuria,6,Elderly adults
colloidal-silver_2015_3,2015,RCT,MD,-2.092,-2.459,-1.726,36,115,some,10.8317/j.jacc.2015.1186,jacc,Colloidal Silver supplement,Placebo,BUN (mg/dL),6,Patients with CKD
colloidal-silver_2011_4,2011,cohort,MD,0.031,-0.256,0.318,31,74,some,10.3725/j.nephrol_dial_transplant.2011.7783,nephrol_dial_transplant,Colloidal Silver supplement,Control group,Proteinuria,12,Elderly adults
colloidal-silver_2022_5,2022,cohort,MD,3.292,2.753,3.83,108,112,low,10.2207/j.am_j_kidney_dis.2022.1547,am_j_kidney_dis,Colloidal Silver supplement,Control group,BUN (mg/dL),4,Elderly adults
